Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

27 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-31

Study Completion Date

2017-06-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to seek to understand the patient's perspective around deciding to participate in a clinical trial for a Hemophilia therapy

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

ATHN 7: Hemophilia Natural History Study

NCT03619863

Hemophilia A With Inhibitor Haemophilia A Without Inhibitor Hemophilia B With Inhibitor +1 more

COMPLETED

Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B

NCT06634836

Hemophilia A Hemophilia B

WITHDRAWN

Learning to Live With Non-severe Haemophilia

NCT05314751

Hemophilia

COMPLETED

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B

NCT01687608

Hemophilia B

ACTIVE_NOT_RECRUITING PHASE1/PHASE2

Liver Biopsy Following Gene Therapy For Hemophilia

NCT05932914

Hemophilia A Hemophilia B

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemophilia B

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants/ Patients

Participants/ Patients from the AskBio009-101 Study

Qualitative Interview - Participants/ Patients

Intervention Type OTHER

Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Participants/ Patients

Investigators and Study Coordinators

Investigators and Study Coordinators from the AskBio009-101 Study

Qualitative Interview - Investigators and Study Coordinators

Intervention Type OTHER

Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Investigators and Study Coordinators

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Qualitative Interview - Participants/ Patients

Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Participants/ Patients

Intervention Type OTHER

Qualitative Interview - Investigators and Study Coordinators

Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Investigators and Study Coordinators

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Were screened and consented for the AskBio009-101study at any point in time
* Are able to speak and understand English
* Are between ages of 18 and 75
* Are physically able to participate in a one-hour phone interview
* Consented into this study independently of the AskBio009-101 study

* Worked at a site as an investigator or study coordinator that consented a patient into the
* AskBio009-101 trial at any point in time, including those that no longer work at a AskBio009-101 site
* Are able to speak and understand English
* Are between ages of 18 and 75
* Are physically able to participate in a one-hour phone interview